Drug regulator asks Serum Institute to increase safety monitors of Covid drug trials

A day after the company halted the trial of the AstraZeneca-Oxford University Covid vaccine in the country. The Drug controller has asked the Pune based company to suspend any new recruitment in the Phase II/III trial till further orders.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news